TEL : 028-85121781
Set Homepage | Add Favorite     中文 | English
Home > Dynamic Center > Enterprise Dynamic >
Enterprise Dynamic
  • Neurosurgery Frontier News showed that, reviewed and approved by Ethics Committee of Beijing Tiantan Hospital, Capital Medical University (Ethics Review Number YW2018-018-01/02/03), chaired by Profess...
    [View details]
  • A Randomized, Controlled, Open-label, Multicenter, Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Chlorogenic Acid for Injection in the Treatment of Recurrent Grade IV Glioblastoma...
    [View details]
  • The clinical trial “A Randomized, Controlled, Open-label, Multicenter, Phase II/III Clinical Trial to Evaluate the Safety and Efficacy of Chlorogenic Acid for Injection in the Treatment of Recurrent G...
    [View details]
  • The Third China BioMed Innovation and Investment Conference was held at the Suzhou BioBay Conference Center on September 18, 2018. At the conference, Jiuzhang Biotech Company presented a special repor...
    [View details]